Artificial intelligence, professionally covered
AI is entering clinics faster than any prior health technology. This hub tracks FDA clearances, radiology and pathology AI, hospital partnerships, drug-discovery breakthroughs and the rules forming around medical AI.
The OpenAI Foundation is funding public health departments to at least double hepatitis C cure rates in two years — and explicitly not requiring them to use OpenAI's tools.
3d ago
AlphaFold's researchers have been reassigned to Gemini-era projects and Isomorphic Labs. The database and servers stay online, and DeepMind's research vice-president says only that 'the strategy has evolved'.
Jul 30, 2026
Bunsen plans, executes and interprets molecular discovery cycles across the company's physics-based tools. What it does not come with is any evidence that it works.
Jul 28, 2026
Natural Cycles needed a fresh 510(k) submission for this model change. The effectiveness figures in the announcement belong to the product it replaces.
Jul 28, 2026
Sheba Medical Center gets early access to OpenAI's medical model suite before the broad American rollout, and sends a delegation to San Francisco in August.
Jul 28, 2026
The Department of Veterans Affairs signed what Salesforce calls an Agentic Enterprise License Agreement — the first time a US federal department has bought agentic AI department-wide rather than as a pilot.
Jul 25, 2026
The January pilot failed for an unexpected reason: 70% of health questions happened outside the dedicated health tab. So OpenAI tore down the tab.
Jul 24, 2026
Scott Winters says GPT-4o talked him out of seeking care before a massive pulmonary embolism — his suit claims the bot practiced medicine without a license and asks a court to halt ChatGPT Health.
Jul 23, 2026
The Palantir-alumni startup's autonomous revenue-cycle platform is growing contracted revenue 190% a year — and Sixth Street just tripled its February 2025 price in 18 months.
Jul 23, 2026
The AI precision-oncology platform is folding tumor-informed molecular residual disease testing into its stack, chasing a US market it sizes at more than $20 billion.
Jul 21, 2026
The pharma giant says it will run proprietary AI models across oncology, immunology and neuroscience on what it calls the most powerful single-owned Nvidia system in life sciences — up to 10x the performance per megawatt of its predecessor.
Jul 20, 2026
RadLE 2.0 tested 16 frontier models on 200 X-ray cases with a scoring system that penalizes confident errors; human radiologists scored 988.7 out of 2,000 to the best AI's 758.
Jul 19, 2026
The Apache-2.0 model reads brain recordings from half a second to 30 seconds long, cleans them up and reconstructs missing channels across setups from consumer headbands to research rigs.
Jul 18, 2026
Google's AI lab is standing up pathogen surveillance, faster vaccine design and a rapid-response drug-discovery unit — explicitly covering both natural outbreaks and AI-enabled misuse.
Jul 17, 2026
The drug-discovery lab's Series C, led by Index Ventures, roughly triples its valuation in seven months as its models push AI-designed antibodies toward Pfizer, Eli Lilly and Novartis.
Jul 15, 2026
In beta since June 30 for paid subscribers, it plugs Claude into 60-plus scientific skills and databases with reproducible, reviewer-checked outputs — plus up to 50 grants of $30,000 to seed real research.
Jul 7, 2026
New 510(k) clearances for brain-tumor and metastasis software from Neosoma and Cercare Medical add to radiology's dominance of FDA-approved medical AI.
Jul 4, 2026
